Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial

Swiss stocks outperform Europe as investors retreat from AI trade - Bloomberg

Investing.com · News 35m ago

Apple Is One of the Most Profitable Businesses in the World. Here's Why the Stock Is Worth $295 a Share Right Now.

NASDAQ · Markets 37m ago

Slide Insurance CRO Matthew Larson sells $307,182 in shares

Investing.com · News 41m ago

US Innovation Foundation director sells $1.6M Linkhome shares privately

Investing.com · News 41m ago

Odd Lots: How to Run a Restaurant For Three Decades (Podcast)

Bloomberg · Markets 42m ago

The Next AI Infrastructure Winner Isn't a Memory Stock. It's This.

NASDAQ · Markets 52m ago

Indonesia Begins Trimming Pipeline Gas Exports to Singapore

Bloomberg · Markets 53m ago

Asana CEO Daniel Rogers sells $226,596 of ASAN shares

Investing.com · News 56m ago

Infosys shares: Should you buy the IT stock after Q2 results, dividend 2026 announcement? Expert view on what to do

LiveMint · Markets 1h ago

UK to inject £20.4 billion into state-backed lenders in budget, FT reports

Investing.com · News 1h ago